Nickel Complexes Bearing SNN and SS Donor Atom Ligands: Synthesis, Structural Characterization and Biological activity
- 9 July 2019
- journal article
- research article
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 33 (9) , e5088
Abstract
Based on a tridentate thiosemicarbazone ligand {HL = 4‐(2,4‐dimethylphenyl)‐1‐((pyridin‐2‐yl)methylene)thiosemicarbazide}, the nickel complexes [NiCl(L)] 1, [Ni(L)(diEtdtc)(H2O)] 2 and [Ni(L)(pipdtc)(H2O)] 3 were prepared {NadiEtdtc = sodium diethyldithiocarbamate and Napipdtc = sodium piperidine dithiocarbamate} and their structures were elucidated according to their elemental analyses, solution conductivities, magnetic moments and spectroscopic (IR and electronic) data. X‐ray single crystal studies have confirmed the structure of 1 as a square planar complex in which each nickel atom is linked to three (two nitrogen and one sulfur) atoms from the thiosemicarbazone ligand and a chlorine atom to ensure the complex neutrality. Moreover, the asymmetric unit cell of the complex was found to consist of two independent complex molecules of slightly different conformations (A&B). The complexes, especially the binary one, displayed high bactericidal activities that, in several instances, were comparable to or higher than those of the chloramphenicol standard.Keywords
This publication has 49 references indexed in Scilit:
- Structural Studies and Investigation on the Activity of Imidazole-Derived Thiosemicarbazones and Hydrazones against Crop-Related FungiMolecules, 2013
- Synthesis, crystal structure, redox behavior and comprehensive studies on DNA binding and cleavage properties of transition metal complexes of a fluoro substituted thiosemicarbazone derived from ethyl pyruvatePolyhedron, 2012
- Synthesis, structures and anti-malaria activity of some gold(i) phosphine complexes containing seleno- and thiosemicarbazonato ligandsDalton Transactions, 2011
- Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine®) in cancer patientsCancer Chemotherapy and Pharmacology, 2010
- A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503Investigational New Drugs, 2009
- Mercury CSD 2.0– new features for the visualization and investigation of crystal structuresJournal of Applied Crystallography, 2008
- A Phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disordersLeukemia Research, 2008
- A short history of SHELXActa Crystallographica Section A Foundations of Crystallography, 2007
- A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret Hospital Phase II consortiumInvestigational New Drugs, 2007
- Characterisation of nickel(II) complexes of a substituted 2-acetylpyridine thiosemicarbazone by electronic and n.m.r. spectral studiesTransition Metal Chemistry, 1991